Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions
PMID: 38488354
Source: Clin Pharmacol Ther
Publication date:
2025-07-24
Year:
2024
Abstract
NULL